Oryzanol ameliorates MCD-induced metabolic dysfunction-associated steatohepatitis in mice via gut microbiota reprogramming and TLR4/NF-κB signaling suppression
American Journal of Physiology-Gastrointestinal and Liver Physiology · 2025
DOI: 10.1152/ajpgi.00190.2024 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Physiology-Gastrointestinal and Liver Physiology, 2025. Verfasst von Naqash Alam und 5 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Animal Center, School of Basic Medical Sciences, Health Science Center, Xi'an Jiaotong University, Xi'an, People's Republic of China. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Toll-Like Receptor 4, NF-kappa B, Phenylpropionates. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 62 Literaturangaben. Gefördert von: 陕西省科学技术厅 | Natural Science Foundation of Shaanxi Province (Shaanxi Natural Science Foundation).
Abstract (Originalsprache)
This study demonstrates that oryzanol (ORY), a bioactive rice bran compound, alleviates metabolic dysfunction-associated steatohepatitis (MASH) in mice by reducing lipid accumulation and inflammation. ORY beneficial effects are associated to the modulation of gut microbiota, enhancing gut barrier integrity, and lowering endotoxemia and TLR4/NF-κB signaling pathway. These findings suggest ORY potential in MASH prevention and treatment, highlighting its influence on gut-liver axis dynamics.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Animal Center, School of Basic Medical Sciences, Health Science Center, Xi'an Jiaotong University, Xi'an, People's Republic of China.
- Institute of Cardiovascular Sciences, School of Basic Medical Sciences, Health Science Center, Xi'an Jiaotong University, Xi'an, People's Republic of China.
ORCID-Profile: Naqash Alam, Sadiq Ali, Enqi Liu
Förderung
- 陕西省科学技术厅 | Natural Science Foundation of Shaanxi Province (Shaanxi Natural Science Foundation)
Zitieren
APA
Alam, N., Ding, X., Fu, Y., Jia, L., Ali, S., & Liu, E. (2025). Oryzanol ameliorates MCD-induced metabolic dysfunction-associated steatohepatitis in mice via gut microbiota reprogramming and TLR4/NF-κB signaling suppression. American Journal of Physiology-Gastrointestinal and Liver Physiology. https://doi.org/10.1152/ajpgi.00190.2024
Vancouver
Alam N, Ding X, Fu Y, Jia L, Ali S, Liu E. Oryzanol ameliorates MCD-induced metabolic dysfunction-associated steatohepatitis in mice via gut microbiota reprogramming and TLR4/NF-κB signaling suppression. American Journal of Physiology-Gastrointestinal and Liver Physiology. 2025. doi:10.1152/ajpgi.00190.2024
BibTeX
@article{Alam2025,
author = {Alam, Naqash and Ding, Xinhua and Fu, Yu and Jia, Linying and Ali, Sadiq and Liu, Enqi},
title = {Oryzanol ameliorates MCD-induced metabolic dysfunction-associated steatohepatitis in mice via gut microbiota reprogramming and TLR4/NF-κB signaling suppression},
journal = {American Journal of Physiology-Gastrointestinal and Liver Physiology},
year = {2025},
doi = {10.1152/ajpgi.00190.2024}
}
EUVIMED